Thrivent Financial for Lutherans’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.3M | Sell |
37,231
-29,717
| -44% | -$16.1M | 0.03% | 455 |
|
|
2025
Q4 | $38.8M | Sell |
66,948
-1,611
| -2% | -$911K | 0.07% | 322 |
|
|
2025
Q3 | $33.3M | Sell |
68,559
-13,573
| -17% | -$6.32M | 0.07% | 309 |
|
|
2025
Q2 | $33.3M | Sell |
82,132
-2,117
| -3% | -$885K | 0.07% | 297 |
|
|
2025
Q1 | $42M | Buy |
84,249
+3,973
| +5% | +$2.15M | 0.09% | 275 |
|
|
2024
Q4 | $41.8M | Sell |
80,276
-2,629
| -3% | -$1.45M | 0.08% | 312 |
|
|
2024
Q3 | $51.3M | Sell |
82,905
-36,714
| -31% | -$21.7M | 0.1% | 268 |
|
|
2024
Q2 | $66.1M | Buy |
119,619
+6,185
| +5% | +$3.54M | 0.13% | 201 |
|
|
2024
Q1 | $65.9M | Buy |
113,434
+17,614
| +18% | +$9.88M | 0.13% | 206 |
|
|
2023
Q4 | $50.9M | Buy |
95,820
+355
| +0.4% | +$172K | 0.11% | 249 |
|
|
2023
Q3 | $48.3M | Buy |
95,465
+1,508
| +2% | +$804K | 0.11% | 239 |
|
|
2023
Q2 | $49M | Buy |
93,957
+68,169
| +264% | +$36.8M | 0.11% | 239 |
|
|
2023
Q1 | $14.8M | Sell |
25,788
-4,453
| -15% | -$2.51M | 0.04% | 498 |
|
|
2022
Q4 | $16.7M | Sell |
30,241
-7,375
| -20% | -$3.91M | 0.04% | 463 |
|
|
2022
Q3 | $19.2M | Sell |
37,616
-225,762
| -86% | -$126M | 0.05% | 402 |
|
|
2022
Q2 | $143M | Sell |
263,378
-6,502
| -2% | -$3.58M | 0.38% | 45 |
|
|
2022
Q1 | $159M | Buy |
269,880
+21,723
| +9% | +$12.5M | 0.31% | 73 |
|
|
2021
Q4 | $164M | Sell |
248,157
-68,909
| -22% | -$43M | 0.32% | 71 |
|
|
2021
Q3 | $181M | Sell |
317,066
-11,913
| -4% | -$6.54M | 0.37% | 53 |
|
|
2021
Q2 | $166M | Sell |
328,979
-14,072
| -4% | -$6.64M | 0.34% | 55 |
|
|
2021
Q1 | $157M | Buy |
343,051
+36,755
| +12% | +$17.5M | 0.34% | 51 |
|
|
2020
Q4 | $143M | Sell |
306,296
-32,169
| -10% | -$15.1M | 0.33% | 56 |
|
|
2020
Q3 | $149M | Sell |
338,465
-48,872
| -13% | -$20.2M | 0.4% | 43 |
|
|
2020
Q2 | $140M | Sell |
387,337
-15,057
| -4% | -$5.05M | 0.42% | 40 |
|
|
2020
Q1 | $114M | Buy |
402,394
+13,658
| +4% | +$4.31M | 0.41% | 43 |
|
|
2019
Q4 | $126M | Sell |
388,736
-40,136
| -9% | -$12.2M | 0.36% | 50 |
|
|
2019
Q3 | $125M | Sell |
428,872
-119,668
| -22% | -$34.3M | 0.39% | 50 |
|
|
2019
Q2 | $161M | Buy |
548,540
+53,717
| +11% | +$14.8M | 0.49% | 34 |
|
|
2019
Q1 | $135M | Buy |
494,823
+67,566
| +16% | +$16.8M | 0.43% | 49 |
|
|
2018
Q4 | $95.6M | Buy |
427,257
+20,985
| +5% | +$4.92M | 0.35% | 59 |
|
|
2018
Q3 | $99.2M | Buy |
406,272
+47,940
| +13% | +$11M | 0.31% | 67 |
|
|
2018
Q2 | $74.2M | Buy |
358,332
+196,272
| +121% | +$41.7M | 0.24% | 90 |
|
|
2018
Q1 | $33.5M | Sell |
162,060
-20,926
| -11% | -$4.39M | 0.11% | 161 |
|
|
2017
Q4 | $34.7M | Buy |
182,986
+4,983
| +3% | +$955K | 0.12% | 166 |
|
|
2017
Q3 | $33.7M | Sell |
178,003
-11,660
| -6% | -$2.11M | 0.12% | 171 |
|
|
2017
Q2 | $33.1M | Buy |
189,663
+175,333
| +1,224% | +$29.5M | 0.14% | 161 |
|
|
2017
Q1 | $2.2M | Buy |
14,330
+570
| +4% | +$87.1K | 0.01% | 811 |
|
|
2016
Q4 | $1.94M | Buy |
13,760
+880
| +7% | +$130K | 0.01% | 872 |
|
|
2016
Q3 | $2.05M | Buy |
12,880
+750
| +6% | +$116K | 0.01% | 860 |
|
|
2016
Q2 | $1.79M | Buy |
12,130
+480
| +4% | +$70.8K | 0.01% | 909 |
|
|
2016
Q1 | $1.65M | Buy |
11,650
+510
| +5% | +$68.3K | 0.01% | 926 |
|
|
2015
Q4 | $1.58M | Buy |
11,140
+290
| +3% | +$38.7K | 0.01% | 919 |
|
|
2015
Q3 | $1.33M | Sell |
10,850
-10,600
| -49% | -$1.38M | 0.01% | 899 |
|
|
2015
Q2 | $2.78M | Buy |
21,450
+500
| +2% | +$65.2K | 0.02% | 596 |
|
|
2015
Q1 | $2.81M | Buy |
20,950
+300
| +1% | +$38.7K | 0.02% | 614 |
|
|
2014
Q4 | $2.59M | Sell |
20,650
-750
| -4% | -$91.2K | 0.01% | 633 |
|
|
2014
Q3 | $2.6M | Buy |
21,400
+250
| +1% | +$30.4K | 0.02% | 621 |
|
|
2014
Q2 | $2.5M | Buy |
21,150
+11,950
| +130% | +$1.41M | 0.01% | 653 |
|
|
2014
Q1 | $1.11M | Buy |
9,200
+800
| +10% | +$95.1K | 0.01% | 701 |
|
|
2013
Q4 | $935K | Buy |
8,400
+100
| +1% | +$9.94K | 0.01% | 779 |
|
|
2013
Q3 | $765K | Sell |
8,300
-4,000
| -33% | -$362K | ﹤0.01% | 778 |
|
|
2013
Q2 | $1.04K | Buy |
+12,300
| New | +$1.02M | 0.01% | 705 |
|
Other funds holding TMO
VCM
Thrivent Financial for Lutherans's TMO Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Thermo Fisher Scientific (TMO) stake by 44% in Q1 2026, selling an estimated $16.1M and leaving 37,231 shares worth $18.3M. The position accounts for 0.03% of the portfolio, ranked #455.
Thrivent Financial for Lutherans first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $181M in Q3 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Thrivent Financial for Lutherans held 37,231 shares of Thermo Fisher Scientific worth $18.3M as of Q1 2026.
- Thrivent Financial for Lutherans sold 29,717 Thermo Fisher Scientific shares in Q1 2026, an estimated $16.1M.
- Thermo Fisher Scientific made up 0.03% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #455 holding.
- Thrivent Financial for Lutherans first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's Thermo Fisher Scientific position peaked at $181M in Q3 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.